Skip to main content

Diagnostic options Β· UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 391–405 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-874
Human Papillomavirus 16 & 18 (HPV) Viral Load Quantitative Test

This test quantifies the amount of HPV DNA from types 16 and 18 in a cervical sample.

Cervical Swab 24 hours (phone) / 3rd working day (email) 900.00 AED
View
View test specifications and preparation
What it measures
["HPV 16 DNA copy number", "HPV 18 DNA copy number"]
Parameters
[]
Preparation
["Avoid intercourse for 48 hours before the test", "Avoid douching for 48 hours before the test", "Avoid vaginal medications/creams/suppositories for 48 hours before the test", "Schedule appointment outside of menstrual period"]
Indications
["Risk stratification for cervical precancer", "Monitoring persistent HPV infection", "Guiding colposcopy decisions", "Assessing treatment response"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 59262-3 ICD-10: B97.7, Z11.51
Clinical summary
This test quantifies the amount of HPV DNA from types 16 and 18 in a cervical sample.
TEST-1496
iAMP21 (Intrachromosomal Amplification of Chromosome 21) FISH Test

This diagnostic test evaluates bone marrow aspirate samples for the presence of intrachromosomal amplification of chromosome 21 (iAMP21) using FISH.

Bone Marrow Aspirate 3–4 working days 700.00 AED
View
View test specifications and preparation
What it measures
["Intrachromosomal Amplification of Chromosome 21 (iAMP21)", "RUNX1 gene amplification"]
Parameters
[]
Preparation
["No specific patient preparation required, sample collected via bone marrow aspiration by a specialist."]
Indications
["Diagnosis and risk stratification of B-cell acute lymphoblastic leukemia (B-ALL)", "Prognostic marker identification in B-ALL"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94373-8 ICD-10: C91.00
Clinical summary
This diagnostic test evaluates bone marrow aspirate samples for the presence of intrachromosomal amplification of chromosome 21 (iAMP21) using FISH.
TEST-4816
ICAM1 Gene Test

This test identifies genetic variants in the ICAM1 gene associated with an increased risk of developing severe cerebral malaria.

Peripheral Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Variants in the ICAM1 gene", "Genetic susceptibility to cerebral malaria"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Risk stratification for cerebral malaria", "Preventive medicine in malaria-endemic travel zones", "Genetic counseling for at-risk individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 91872-4 ICD-10: Z13.79
Clinical summary
This test identifies genetic variants in the ICAM1 gene associated with an increased risk of developing severe cerebral malaria.
TEST-4943
ICOS Gene Common Variable Immunodeficiency Typeβ€―1 (CVID1) Next‑Generation Sequencing (Genetic Test

This genetic test analyzes the ICOS gene for pathogenic variants associated with common variable immunodeficiency type 1 (CVID1). It helps identify the genetic basis for this prima...

Peripheral Whole Blood (3–5 mL in EDTA), or DNA extracted from blood. FTA cards accepted with pre-approval. 3–4 Weeks (expedited options available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ICOS gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number alterations"]
Parameters
[]
Preparation
["No special preparation (fasting) is needed."]
Indications
["Suspected diagnosis of Common Variable Immunodeficiency Type 1 (CVID1)", "Family history of CVID1", "Guiding immunoglobulin replacement therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101377-5 ICD-10: D83.0
Clinical summary
This genetic test analyzes the ICOS gene for pathogenic variants associated with common variable immunodeficiency type 1 (CVID1). It helps identify the genetic basis for this primary immunodeficiency.
TEST-1480
IGHV Mutation Load Test

This test evaluates the somatic hypermutation status of the immunoglobulin heavy-chain variable gene (IGHV) in blood or bone marrow samples.

Bone Marrow / Peripheral Blood 7–8 working days 1,000.00 AED
View
View test specifications and preparation
What it measures
["Somatic hypermutation status of IGHV gene", "Prognostic marker for CLL"]
Parameters
[]
Preparation
["Fasting is not required.", "Inform the medical team if you are on anticoagulants or have a bleeding disorder."]
Indications
["Diagnosis and prognosis of Chronic Lymphocytic Leukemia (CLL)", "Risk stratification in CLL patients"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 98108-3 ICD-10: C91.1
Clinical summary
This test evaluates the somatic hypermutation status of the immunoglobulin heavy-chain variable gene (IGHV) in blood or bone marrow samples.
TEST-3346
IGLL1 Gene Agammaglobulinemia Type 2 Autosomal Recessive Genetic Test

This genetic test identifies pathogenic variants in the IGLL1 gene, confirming a diagnosis of autosomal recessive agammaglobulinemia type 2.

Whole Blood, Extracted DNA, FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the IGLL1 gene", "Presence of mutations causing agammaglobulinemia type 2"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab if patient received allogeneic hematopoietic stem cell transplant within 6 months"]
Indications
["Suspected primary immunodeficiency", "Diagnosis of autosomal recessive agammaglobulinemia type 2", "Family history of immunodeficiency"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94017-7 ICD-10: D80.0
Clinical summary
This genetic test identifies pathogenic variants in the IGLL1 gene, confirming a diagnosis of autosomal recessive agammaglobulinemia type 2.
TEST-1713
IgVH Hypermutation Analysis Confirmatory Test

This test evaluates the somatic hypermutation status of the immunoglobulin heavy chain variable gene (IgVH) in peripheral blood.

Peripheral whole blood (lavender-top EDTA tube) 10 working days from sample receipt 3,500.00 AED
View
View test specifications and preparation
What it measures
["Somatic hypermutation status of IgVH gene", "Derived ratio analysis"]
Parameters
[]
Preparation
["No fasting or special preparation required", "Sample collected in a lavender-top EDTA tube"]
Indications
["Prognostic stratification in CLL", "Guiding treatment decisions (watch-and-wait vs. early intervention) in CLL"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81264-9 ICD-10: C91.1
Clinical summary
This test evaluates the somatic hypermutation status of the immunoglobulin heavy chain variable gene (IgVH) in peripheral blood.
TEST-4706
IL1RN Gene Mutation Analysis (DIRA) Test

This test identifies mutations in the IL1RN gene, which cause Deficiency of Interleukin-1 Receptor Antagonist (DIRA).

Whole blood (EDTA) or FTA card 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["IL1RN gene sequence", "Copy Number Variations (CNVs) in IL1RN gene", "Exon-intron boundaries", "5'/3' UTR regions"]
Parameters
[]
Preparation
[]
Indications
["Suspected Deficiency of Interleukin-1 Receptor Antagonist (DIRA)", "Infants presenting with sterile osteomyelitis and pustular rash", "Family history suggestive of DIRA"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: D89.89
Clinical summary
This test identifies mutations in the IL1RN gene, which cause Deficiency of Interleukin-1 Receptor Antagonist (DIRA).
TEST-199
Illumina-Based Bacterial Genome De Novo Assembly and Annotation Test

This test evaluates the complete genetic sequence of a bacterial isolate to identify resistance genes, virulence factors, and strain characteristics.

Bacterial isolate (pure culture) 4 weeks 2,500.00 AED
View
View test specifications and preparation
What it measures
["Whole bacterial genome sequence", "Antibiotic resistance genes", "Virulence factors", "Mobile genetic elements", "Strain-level typing (MLST)", "Plasmid content"]
Parameters
[]
Preparation
["No special preparation needed for blood culture.", "Follow physician's instructions for other specimen types (sputum, urine, swab)."]
Indications
["Complex or recurrent infections", "Outbreak investigations", "Suspected antibiotic resistance", "Need for precise pathogen identification", "Epidemiological surveillance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94061-3 ICD-10: B96.89
Clinical summary
This test evaluates the complete genetic sequence of a bacterial isolate to identify resistance genes, virulence factors, and strain characteristics.
TEST-1716
Imatinib Resistance Mutation Analysis (IRMA) Test

This test identifies specific mutations within the BCR-ABL kinase domain that confer resistance to imatinib and other TKIs.

Whole Blood (Peripheral) 6 business days from sample receipt 1,100.00 AED
View
View test specifications and preparation
What it measures
["BCR-ABL kinase domain mutations", "Variant Allele Frequency (VAF)"]
Parameters
[]
Preparation
["No fasting required.", "No specific medication or diet restrictions."]
Indications
["Confirmed loss of molecular response to imatinib", "5-10 fold rise in BCR-ABL transcripts", "Progression to accelerated or blast phase disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 76057-7 ICD-10: C92.10
Clinical summary
This test identifies specific mutations within the BCR-ABL kinase domain that confer resistance to imatinib and other TKIs.
TEST-481
Immigration DNA Relationship Test

This test confirms or excludes biological relationships (parentage, maternity, siblingship) using forensic DNA genotyping.

Buccal Swab (Oral Mucosa) 10–12 Business Days 3,500.00 AED
View
View test specifications and preparation
What it measures
["Autosomal STR markers", "Y-STR markers"]
Parameters
[]
Preparation
["No fasting required", "Do not discontinue prescribed medications without consulting a doctor"]
Indications
["Establishing parentage for visa applications", "Family reunification cases", "Sponsorship applications", "Citizenship applications"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21642-2 ICD-10: Z13.89
Clinical summary
This test confirms or excludes biological relationships (parentage, maternity, siblingship) using forensic DNA genotyping.
TEST-3713
Intellectual Disability Panel (NGS) Genetic Test

This test identifies pathogenic and likely pathogenic variants in over 600 genes associated with intellectual disability and related neurodevelopmental conditions using Next-Genera...

Peripheral Whole Blood (EDTA) 3–4 weeks 3,000.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of intellectual disability", "Identification of genetic cause for neurodevelopmental disorders", "Guiding therapeutic and educational interventions", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93882-9 ICD-10: F70-F79
Clinical summary
This test identifies pathogenic and likely pathogenic variants in over 600 genes associated with intellectual disability and related neurodevelopmental conditions using Next-Generation Sequencing.
TEST-2303
Interleukin 28B (IL28B) rs12979860 & rs8099917 Genotyping Test

This test evaluates specific genetic variations (SNPs) in the IL28B gene associated with hepatitis C virus (HCV) treatment response and disease progression.

Whole Blood (EDTA) 2–4 Working Days 1,100.00 AED
View
View test specifications and preparation
What it measures
["rs12979860 SNP", "rs8099917 SNP"]
Parameters
[]
Preparation
["No fasting required", "No special diet or medication adjustments needed", "Inform the team of any anticoagulant therapy"]
Indications
["Predicting response to interferon-based therapy for Hepatitis C", "Assessing risk of liver disease progression in Hepatitis C"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 72517-6 & 72518-4 ICD-10: Z22.52
Clinical summary
This test evaluates specific genetic variations (SNPs) in the IL28B gene associated with hepatitis C virus (HCV) treatment response and disease progression.
TEST-2288
Inv(16)(p13q22) / t(16;16)(p13q22) Gene Rearrangement Qualitative PCR Test

This test detects the presence or absence of the CBFB-MYH11 gene rearrangement, a specific genetic marker found in certain types of acute myeloid leukemia (AML).

Whole Blood or Bone Marrow Aspirate Sample Mon/Thu by 11 am β†’ Report Wed/Sat 800.00 AED
View
View test specifications and preparation
What it measures
["CBFB-MYH11 gene rearrangement", "Presence of inv(16)(p13q22) or t(16;16)(p13q22) translocation"]
Parameters
[]
Preparation
["No specific patient preparation required", "Sample collection must be performed in an accredited hospital facility"]
Indications
["Diagnosis of AML", "Risk stratification in AML", "Minimal residual disease (MRD) monitoring in AML"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 33680-6 ICD-10: C92.8
Clinical summary
This test detects the presence or absence of the CBFB-MYH11 gene rearrangement, a specific genetic marker found in certain types of acute myeloid leukemia (AML).
TEST-2320
Inv(16)(p13q22)/t(16;16)(p13;q22) Gene Rearrangement Quantitative MRD Monitoring Test

This test quantifies the level of CBFB-MYH11 fusion transcripts in blood or bone marrow to detect minimal residual disease (MRD) in AML patients with the inv(16)/t(16;16) rearrange...

Peripheral blood (10 mL EDTA) or bone marrow (2–3 mL EDTA) 4 Days from sample receipt (samples collected Mon/Thu by 11 am; reports Wed/Sat) 1,000.00 AED
View
View test specifications and preparation
What it measures
["CBFB-MYH11 fusion transcripts", "Minimal Residual Disease (MRD)"]
Parameters
[{"name": "MRD Level", "reference_range": "
Preparation
["No special preparation required", "Provide completed MRD Requisition Form with historical data"]
Indications
["Monitoring AML patients with inv(16)/t(16;16) rearrangement", "Assessing response to therapy", "Detecting early molecular relapse"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 69125-5 ICD-10: C92.0
Clinical summary
This test quantifies the level of CBFB-MYH11 fusion transcripts in blood or bone marrow to detect minimal residual disease (MRD) in AML patients with the inv(16)/t(16;16) rearrangement.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area